Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

A day in the life of a PR Account Director

We asked Laura Glover to give us an insight into her role as a PR Account Director at OPEN Health

OPEN Health

Lucid Group’s winning talent team

The Lucid Group talent team has grown with two new Talent Acquisition Partners: Jon Turner and Ellen Field. To help you understand a bit more about them, their role, and the opportunities...

Lucid Group Communications Limited

- PMLiVE

Why you should feel optimistic about the future of healthcare

It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic.

Say Communications

- PMLiVE

Are healthcare brands finally wising up to the power of creative-led communications?

By Ishtar Schneider and Esin Cittone

- PMLiVE

Valneva shares fall as UK cancels COVID-19 vaccine order

The UK government has cancelled a supply agreement for French vaccine maker Valneva’s COVID candidate VLA2001 over an alleged breach of obligations.

- PMLiVE

AbbVie signs gene therapy deal in eye care

AbbVie and REGENXBIO have teamed up on RGX-314, a potential one-time gene therapy against two leading causes of blindness, wet AMD and diabetic retinopathy.

- PMLiVE

David Hunt launches independent agency The Considered

The team includes Professor Shafi Ahmed, Aurora Archer, Jane Kidd and CCO Pete Armstrong

Solving healthcare problems: What needs to change?

In this month’s PME, Tanya Goodyear, Director of Innovation and Transformation at Lucid Group, details Lucid’s approach to solving healthcare problems and reflects on the learnings we can draw from...

Lucid Group Communications Limited

Patient-centred drug development: how far have we come and what’s next?

By Jo Fearnhead-Wymbs

- PMLiVE

Mastering oneself

What does it take to be a biomedical strategy expert?

David Youds, Barney Mayles, Resonant Group

RESONANT GROUP ACQUIRES PR BUSINESS

Affirms Resonant’s mission to enable effective engagement in health

Bedrock Healthcare Communications

Biogen Idec building

Embattled Biogen talks up Aduhelm

Biogen CEO admitted the company was experiencing “near-term challenges” after the controversial approval of Alzheimer’s drug, Aduhelm

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links